CDT Equity Inc. (CDT) stock
CDTNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as CDTTW
$0.38−0.02 (-5.84%)
Close on Nov 16, 2026Market cap $296.58KP/E –Yield –
CDT Equity operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
CDT Equity's operating cash flow for the twelve months ending Jun 30, 2026 was -$11.48M. For fiscal 2025 it was -$15.56M.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$15.56M | – |
| FY2024 | Dec 31, 2024 | -$9.68M | – |
| FY2023 | Dec 31, 2023 | -$7.73M | – |
| FY2022 | Dec 31, 2022 | -$2.27M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$544.00K | – |
| Q1 FY2026 | Mar 31, 2026 | -$1.89M | – |
| Q4 FY2025 | Dec 31, 2025 | -$4.64M | – |
| Q3 FY2025 | Sep 30, 2025 | -$4.41M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.58M | – |
| Q1 FY2025 | Mar 31, 2025 | -$3.93M | – |
| Q4 FY2024 | Dec 31, 2024 | -$3.81M | – |
| Q3 FY2024 | Sep 30, 2024 | -$2.00M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.51M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.36M | – |
| Q4 FY2023 | Dec 31, 2023 | -$4.80M | – |
| Q3 FY2023 | Sep 30, 2023 | -$524.00K | – |
| Q2 FY2023 | Jun 30, 2023 | -$428.00K | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.97M | – |
| Q4 FY2022 | Dec 31, 2022 | -$880.00K | – |
| Q3 FY2022 | Sep 30, 2022 | -$566.60K | – |
| Q2 FY2022 | Jun 30, 2022 | -$126.92K | – |
| Q1 FY2022 | Mar 31, 2022 | -$692.49K | – |
See a number that looks wrong?